PhotonPharma

PhotonPharma is a biotechnology company focused on developing and commercializing innovative cancer immunotherapies. Their flagship technology is Innocell™, an autologous cell therapy platform that utilizes a patient's own tumor cells to create a personalized vaccine. This approach aims to stimulate the immune system to recognize and destroy both the primary tumor and any metastatic cells. PhotonPharma has garnered significant funding, including a $2.5 million seed round, and has secured FDA clearance for a first-in-human clinical study for their ovarian cancer treatment.

The company is based in Fort Collins, Colorado, and has a strong connection to Colorado State University (CSU). They have a team of experienced professionals, including a dedicated leadership team and a board of directors with expertise in research, development, and clinical affairs. PhotonPharma's research has been published in peer-reviewed journals and they have presented at prominent industry events, showcasing their commitment to advancing innovative cancer treatments.

PhotonPharma is a biotechnology company dedicated to developing and commercializing innovative cancer immunotherapies. Their primary focus is on the Innocell™ platform, an autologous cell therapy that utilizes a patient's own tumor cells to stimulate a personalized immune response against cancer. PhotonPharma strives to provide patients with a safe and effective treatment option, particularly for those with solid tumor cancers, by making tumor cell antigens visible to the immune system and activating it to destroy both the primary tumor and any metastatic cells.

PhotonPharma fosters a collaborative and innovative culture, prioritizing research and development of its groundbreaking cancer immunotherapy technology. The company values teamwork, with diverse expertise across scientific, clinical, and business sectors, and is committed to supporting the professional growth of its employees. This culture is evident in their open communication, interdisciplinary collaboration, and investment in employee development, including internship programs and academic partnerships.